RMD

Resmed

Stock NYSE – Stock Market Prices, News & Analysis

Company specialized in the manufacturing and distribution of medical devices for the treatment of respiratory disorders, including sleep apnea.

$ 239.44
2.33 %

Resmed

$ 239.44
2.33 %
RMD

Company specialized in the manufacturing and distribution of medical devices for the treatment of respiratory disorders, including sleep apnea.

Price history of Resmed
Price history of Resmed

Performance & Momentum

6 Months 8.21 %
1 Year 14.48 %
3 Years 19.83 %
5 Years 44.05 %
Momentum
79

Strategic Analysis

Resmed • 2026

Resmed Inc is a niche player in the medical devices sector, specializing in technological solutions for the treatment of respiratory disorders, particularly sleep apnea. Its model is based on continuous innovation and a strong presence in the American market, with a solid positioning in a growing segment related to respiratory health needs.

Strengths
  • Strong technological expertise targeted at a medical segment with high barriers to entry
  • Diversified product portfolio covering both devices and connected solutions
  • Current business model sustained by the sale of consumables and associated services
Weaknesses
  • Sensitivity to regulatory and healthcare policy changes in the United States
  • Increasing competition, notably from international players and alternative solutions
Momentum

After a recent period marked by a downturn, the medium-term momentum remains positive, supported by stable demand in chronic respiratory care. The absence of recent unfavorable news suggests potential for stabilization or even gradual recovery, but investors should remain vigilant regarding macroeconomic risks affecting the healthcare sector.

Analysis performed 1 week ago

Similar stocks to Resmed

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone